Neurostimulation
Beckennerven

Die Neurostimulation ist ein junges und dynamisches
medizinisches Feld mit einer ganzen Reihe von Ansätzen.

Management Team

  • FOUNDER – CEO/CSO/CFO 

Prof. Prof. (DK) Prof. h.c. (China) Dr. med. Marc Possover, MD, PhD

Prof. HPL University Cologne, Germany
Ass. Prof. University Aarhus, Denmark
Honorary Professor University Xi’An – China
Member of the French National Academy of Surgery- www.academie-chirurgie.fr
Founder & Honorary President/Chairman, International Society of Neuropelveology (www.theison.org)
Member of the Scientific Advisory Board of the Endometriosis Foundation of America (www.endofound.org)
Ambassador of the World Endometriosis Society
Director International School of Neuropelveology (ISNP) (www.possover-neuropelveology.com)

CV

  • Dipl. ing. Gerhard Seiler, PhD –  CTO/CPO/CMO

Experience:

1989-1993: Ass. Professor TU of Munich (G)
1993-2008: Practice manager European Product Development Practice / Senior practice expert product development – McKinsey & Company, Inc. (Munich, G)
2008-2014: Vice president, program leader Value Engineering – Philips (Eindhoven, ND)
2014-2015: Senior Manager Value Engineering & Benchmarking – Zumtobel Group (Doenbirn, A)
2015-2018: Senior director Design-to-Value – Johnson & Johnson, Inc. (Zug, CH)
Since 2018: Self-employed, CEO, VE Expert Network GmbH (Zug, CH)

Interim Management Assignment NEUROGYN CTO since 2021

  • Dipl. Ing. Monir El Azzouzi, Msc – CQO/CRO/CIO

Experience:

Executive leader with expertise in all facets of leadership, global operations, Quality Management, Regulatory Affairs for medical devices within international organizations. Broad knowledge & skills in developing, implementing, and managing complex product development. Extensive experience providing in-depth k owl edge and expertise with int. companies. Imnstrumental in streaming and improving processes, enhancing productivity, and implementing global quality and regulatory solutions.

2005-2006: Msc. Master Management of Quality and Key Performance (Besancon, F)
2002-2005: Master Biomedical Engineering – ISIFC (Besancon/F)
1999-2002: Medicine University (Besancon, F)
2005-2006:  QA/RA Manager – Aesculap (Braun Medical)
2010-2011: Head of QA/RA Scient’X (Alphatec Spine)
2011-2013: Global Regulatory Affairs Manager – Bausch & Lomb (Zug, CH)
2013-2015: EMEA Quality & Regulatory Compliance Manager – J&J (Zug, CH)
2015-2019: Plant Senior Quality Manager & Quality Operation Manager – Depuy Synthes – J&J
Since 2019: Founder & CEO „Easy Medical Device“  Cert. & Inspection ISO 13485:2016 / MDSAP / FDA / Medical Device CE Marking / In-Vitro Diagn. CE marking / ISO 19011
Easy Medical Device - Homepage

On September 24, 2014, Prof. Possover founded NeuroGyn AG (NeuroGyn) as the sole shareholder. Its legal seat is in Zug, Switzerland.

NeuroGyn is a Swiss-based Medtech Company developing and marketing innovative solutions in the field of neurotechnology for international medical markets. NeuroGyn’s mission is to assist physicians in improving the quality of life for millions of patients with dysfunctions of the pelvic nerve system by providing stimulation systems and relevant accessories.

Atypical for a startup, the initial work involved a combination of scientific/clinical research and the development of a patent portfolio on both surgical techniques of implantation (GNS  and LION procedures) and corresponding indications, including significant market issues such as overactive bladder (OAB), osteoporosis and erectile dysfunction.

The NeuroGyn pacemaker was developed in response to the needs of gynecologists and neuropelveologists for pelvic neuromodulation. The unique target area and patients’ needs present challenges for the implant, and even the advanced Western healthcare system cannot currently provide adequate solutions available on the market. A dedicated Pelvic Neurostimulator designed for this unique target area and population will be a groundbreaking solution, transforming the pelvic neuromodulation market.